| Literature DB >> 35956759 |
Yawen Zeng1, Jiazhen Yang2, Jia Chen1, Xiaoying Pu1, Xia Li1, Xiaomeng Yang1, Li'e Yang1, Yumei Ding1, Mingying Nong3, Shibao Zhang3, Jinbao He3.
Abstract
Medicinal and food homologous adlay (Coix lachryma-jobi L. var. ma-yuen Stapf) plays an important role in natural products promoting human health. We demonstrated the systematic actional mechanism of functional ingredients in adlay to promote human health, based on the PubMed, CNKI, Google, and ISI Web of Science databases from 1988 to 2022. Adlay and its extracts are rich in 30 ingredients with more than 20 health effects based on human and animal or cell cultures: they are anti-cancer, anti-inflammation, anti-obesity, liver protective, anti-virus, gastroprotective, cardiovascular protective, anti-hypertension, heart disease preventive, melanogenesis inhibiting, anti-allergy, endocrine regulating, anti-diabetes, anti-cachexia, osteoporosis preventive, analgesic, neuroprotecting, suitable for the treatment of gout arthritis, life extending, anti-fungi, and detoxifying effects. Function components with anti-oxidants are rich in adlay. These results support the notion that adlay seeds may be one of the best functional foods and further reveal the action mechanism of six major functional ingredients (oils, polysaccharides, phenols, phytosterols, coixol, and resistant starch) for combating diseases. This review paper not only reveals the action mechanisms of adding adlay to the diet to overcome 17 human diseases, but also provides a scientific basis for the development of functional foods and drugs for the treatment of human diseases.Entities:
Keywords: actional mechanisms; adlay; anti-cancer; anti-diabetic; anti-inflammatory; anti-obesity; anti-oxidant; functional ingredient; medicine and food homologous
Mesh:
Substances:
Year: 2022 PMID: 35956759 PMCID: PMC9369982 DOI: 10.3390/molecules27154808
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Nutrition and functional ingredients in different tissues of adlay [14].
| Components | Adlay | Adlay | Adlay | Adlay | Adlay | Adlay |
|---|---|---|---|---|---|---|
| Total Ash (%) | 2.65 | 15.68 | 21.32 | 5.89 | 1.83 | 14.70 |
| Protein (%) | 19.33 | 10.85 | 7.56 | 19.06 | 12.07 | 18.29 |
| Crude fiber (%) | 2.05 | 53.56 | 45.43 | 28.78 | 43.44 | 18.95 |
| Crude fat (%) | 4.70 | 5.31 | 4.52 | 7.15 | 2.44 | 0.38 |
| Polysaccharides (%) | 2.26 | 0.65 | 0.52 | 0.53 | 0.28 | 0.47 |
| Starch (%) | 48.58 | 3.55 | 4.56 | 6.78 | 8.89 | 3.21 |
| VE (mg/kg) | 86.61 | 106.85 | 119.27 | 146.5 | 109.32 | 112.36 |
| VC (mg/kg) | 0.11 | 5 0.08 | 0.12 | 8 0.26 | 0.28 | 0.31 |
| VB1 (mg/kg) | 0.51 | 0.56 | 0.42 | 0.61 | 0.44 | 0.58 |
| VB2 (mg/kg) | 0.62 | 0.78 | 1.28 | 2.96 | 1.66 | 0.99 |
| VB6 (mg/kg) | 8.38 | 9.09 | 12.66 | 21.64 | 7.72 | 40.07 |
| VB12 (mg/kg) | 0.54 | 0.66 | — | 1.32 | 0.43 | 0.89 |
| Folciate acid (mg/kg) | 0.12 | — | 0.05 | 2.51 | 1.97 | 8.85 |
| Nicic acid (mg/kg) | 12.36 | 14.97 | 13.21 | 4.92 | — | 3.27 |
| K (mg/kg) | 2165.50 | 2294.61 | 1987.05 | 3714.79 | 2468.96 | 4175.83 |
| Ca (mg/kg) | 305.39 | 609.51 | 875.69 | 1845.33 | 1374.30 | 15,645.02 |
| Na (mg/kg) | 1020.42 | 1231.67 | 1393.59 | 877.92 | 1060.83 | 1904.38 |
| Mg (mg/kg) | 1212.29 | 1481.48 | 1567.37 | 2385.63 | 2283.13 | 5845.83 |
| Zn (mg/kg) | 146.83 | 88.93 | 91.36 | 84.01 | 20.91 | 41.22 |
| Fe (mg/kg) | 116.23 | 107.89 | 90.47 | 1459.28 | 98.92 | 367.18 |
| P (mg/kg) | 1933.20 | 323.93 | 318.92 | 849.51 | 391.89 | 1405.92 |
| Se (mg/kg) | 0.04 | 0.09 | 0.07 | 0.11 | — | 0.04 |
| Total amino acids (%) | 14.400 | 3.804 | 1.654 | 6.612 | 3.394 | 8.278 |
| Palmitate * (%) | 0.68 | 8.42 | 10.52 | 8.42 | 9.53 | 7.93 |
| Palm-linoleic acid * (%) | 0.59 | — | — | 1.36 | — | — |
| Stearic acid * (%) | 5.64 | 2.35 | 1.96 | 3.35 | 2.12 | 2.93 |
| Oleic acid * (%) | 40.59 | 43.55 | 21.17 | 26.74 | 43.87 | 46.11 |
| Linoleic acid * (%) | 26.53 | 31.18 | 14.49 | 18.78 | 29.88 | 33.47 |
| Decoanic acid * (%) | 1.10 | 1.04 | 0.90 | 0.75 | 0.87 | 1.24 |
| Eoixol (mg/g) | 0.14 | 0.25 | 0.23 | 1.26 | 0.34 | 0.34 |
| Flavonoids (mg/g) | 2.26 | 0.13 | 0.09 | 0.21 | 0.44 | 2.13 |
| Total phenol (mg/g) | 0.27 | 1.89 | 1.04 | 4.53 | 3.07 | 3.15 |
Note: * Refers to the percentage of six monomeric fatty acids in the total fatty acids.
Nutrition and functional ingredients of adlay seeds.
| Composition | Mean ± SD | Range | References |
|---|---|---|---|
| Polysaccharides (%) | 1.59 ± 0.95 | 0.92–2.26 | [ |
| Total starch (%) | 65.54 ± 3.28 | 57.82–71.51 | [ |
| Amylase (%) | 4.87 ± 5.69 | 0.00–25.48 | [ |
| Resistant starch (%) | 5.57 ± 0.08 | 5.49–5.65 | [ |
| Lipid (fat+oil) (%) | 7.82 ± 0.60 | 6.32–9.13 | [ |
| Triolein (%) | 0.82 ± 0.19 | 0.53–1.04 | [ |
| Protein (%) | 18.18 ± 1.36 | 14.77–21.78 | [ |
| Total amino acid (%) | 17.38 ± 1.21 | 14.02–20.67 | [ |
| Flavonoids (mg/g) | 1.24 ± 1.44 | 0.22–2.26 | [ |
| Polyphenols (mg/g) | 0.81 ± 0.76 | 0.27–1.35 | [ |
| Eoixol (mg/g) | 29.92 ± 42.12 | 0.14–59.70 | [ |
| γ-oryzanol (μg/g) | 271.64 ± 101.36 | 176.52–375.35 | [ |
| γ-Tocopherol (μg/g) | 29.72 ± 10.34 | 22.41–37.03 | [ |
Note: Total starch includes amylose and resistant starch, lipids include fats and oils as well as triolein, and protein includes total amino acids.
Action pathway and functional ingredients of adlay in the treatment 13 cancer types.
| Pharmaco- | Anti- | Action Pathway | Functional Ingredients | References |
|---|---|---|---|---|
| Inhibiting tumor micro- angiogenesis | Cervical cancer | Inhibiting vascular endothelial factor secretion and its receptor activity | Besterol, β-glusterol | [ |
| Induced the apoptosis of cancer cells | Cervical cancers | Inactivation of the PI3K/AKT pathway in HeLa cells inhibited tumor cell proliferation, enhanced anti-angiogenesis, and induced apoptosis by regulating bax/ bcl-2 and the activating caspase-3 pathway. | Transferrin-functionalized microemulsions coloaded; Coix seed oil (human clinical trials) | [ |
| Hepatoma cancer | Regulating the expression of caspase-8; the half- maximal inhibitory effect against HepG2 cells was 46.5 ± 2.4μg/mL | Octanoyl galactose ester; adlay extract (in vitro, in vivo) | [ | |
| Pancreatic Cancer | Downregulation of BCL-2 protein expression, increased expression of the Fas gene, apoptosis by activating caspase-3 and increasing the Bax/Bcl-2 ratio, and inhibition of NF-κB activity and downstream target genes. | Triglycerides, Coixenolide, | [ | |
| Early mature leukemia | Activated apoptotic protein Caspase-3, induced mitochondrial apoptosis, and promoted cell apoptosis. | Coixenolide | [ | |
| Non-small cell lung cancer | Activating the endogenous mitochondrial apoptosis pathway and activating the apoptotic proteins Caspase-6 and Caspase-9 and promotes apoptosis. | Polysaccharides | [ | |
| Inhibiting cancer cell metastasis | Colorectal | Inhibits the tumor necrosis factor-α-mediated epithelial mesenchymal transition via the inhibition of NF-κΒ. | Resistant starch, coix seed oil | [ |
| Colon cancer | HUVECs via repression of the ERK1/2 and AKT pathways. | Adlay sprout extract | [ | |
| Non-small cell lung cancer | Downregulation of S100 calcium-binding protein and A4 expression and supports the expression of proliferative proteins, invasive proteins, matrix proteins, and the JAK2/STAT3 signaling pathway. | Polysaccharides, | [ | |
| Laryngeal cancer | Inhibits the expression of invasion and transfer factors. | Triglycerides, Coixenolide, Coixol (human clinical trials) | [ | |
| Suppress the cancer cell proliferation | Breast cancer | miR-205/S1PR1 regulate sphingomyelin metabolism, downstream STAT3/MAPK/AKT signal pathways. | Coix seed oil | [ |
| Endometr- | Ethyl acetate showed dose-dependent cell cycle arrest of HEC-1A and RL95-2 cells at the sub G1 checkpoint and G2/M checkpoint. | Polyphenols, Flavonoids, Phytosterols, Fatty acid | [ | |
| Laryngeal cancer | Meddling with protein phosphatase 2A in the sphingom-yelin cycle and blocking the cell cycle at the G0/G1 phase. | γ-oryzanol, Coixenolide | [ | |
| Myterine oma | Inhibits ustrosphyperplasia induced by sex hormone hexene estrogol/methoxyprogesterone 17-acetate. | Besterol, β-glusterol | [ | |
| Gastric cancer | Inhibits Bcl-2 gene expression and blocks cancer cells in the G1 cycle. | Triglycerides, Coixenolide, | [ | |
| Lung cancer | Suppresses cytocyclin A expression and blocks cancer cell proliferation during the cell cycle G1/S transition. | Adlay extract, Triterpene | [ | |
| Uterine leiomyoma | Reduced diethylstilbestrol/medroxyprogesterone 17-acetate-induced uterine myometrial hyperplasia. | Stigmasterol, β-sitosterol | [ | |
| Anti-cachexia | Lewis lung cancer | Adjusts the NF-κB-MuRF1 and AMPK-HSL pathways to inhibit elevated inflammatory factors and leads to phosphorylation of HSL to avoid fat and muscle loss. | Coix seed oil | [ |
Action pathway and functional ingredients of adlay in preventing chronic diseases other than cancers.
| Chronic Diseases | Action Pathway | Functional Ingredients | References |
|---|---|---|---|
| Anti- | Cell membrane into the cytosol and nucleus, triggering gene expression, changes in cell proliferation, and the induction of apoptosis; increased cellular production of nitric oxide and prostaglandin E2 by downregulating nitric oxide synthase and cyclooxygenase 2 expression. | Polyphenols, coixol, | [ |
| Anti-obesity | Glycerolipid metabolism, biosynthesis of unsaturated fatty acids, sulfur reduction, and glutathione transport system; AMP-activated protein kinase in adipose differentiation decrease adipogenesis expression and enhances binding protein α. | Polyphenols, dietary fiber, adlay extract, | [ |
| Protective liver | Inhibiting vascular endothelial factor secretion and its receptor activity. | Besterol, β-glusterol | [ |
| Anti-virus | Increase in peripheral cytotoxic lymphocytes and enhanced cytotoxic activity. | Adlay extract | [ |
| Cardiovascular protection | Reduced serum cholesterol and low-density lipoprotein cholesterol and improved high-density lipoprotein cholesterol. | Polyphenol | [ |
| Gastro- | Reducing the pH value of gastric juice, increasing the density and length of gastrointestinal villi, and modulating gut microbiota. | Phenolic acids, caffeic, | [ |
| Anti- | Angiotensin converting enzyme inhibitory peptide GAAGGAF by glutelin and polypeptides produced by gluten; high angiotensin I conversion of enzyme inhibitory activity tetrapeptide downregulated expression. | Glutelin, | [ |
| Preventive heart disease | Assembled gene sets by the levels of prolamin and vitamin E biosynthesis-associated protein; blood lipid-reducing and anti-oxidant effects. | Vitamin E, | [ |
| Anti-allergy | Inhibit mast cell degranulation, suppress the production of Akt, influence the signal transduction in cells; inhibitory effect on allergic response via the ERK signaling transduction in RBL-2H3 cells. | Phenolic acids; | [ |
| Melanogenesis inhibition | Reduce tyrosinase activity and melanin production in melanoma cells, which has a tyrosinase inhibitor and anti-hyperpigmentation agent. | Adlay bran oil, coixol | [ |
| Endocrine regulation | Decrease testosterone release via the inhibition of the protein kinase A/C signal transduction pathways; GnRH-induced luteinizing hormone secretion; inhibited progesterone secretion and reduced cAMP, PKC, and post-cAMP pathway action. | Methanol extracts of adlay hull | [ |
| Anti-diabetes | Improve insulin resistance by inhibition of the IKK/NF-κB inflammatory pathway; regulation of the intestinal microbiota and its metabolic pathways. | Protein, resistant starch; polysaccharides | [ |
| Anti-cachexia | Counteract muscle and adipose tissue loss through regulating the NF-κB-MuRF1 and AMPK-HSL pathways. | Coix seed oil | [ |
| Preventive osteoporosis | Increase the proliferation of osteoblast cells via an extracellular signal-regulated kinase-regulated signaling pathway. | Water extract of adlay | [ |
| Neuroprotect- | Aβ25-35-induced apoptosis in dPC12 cells was associated with the enhancement of the PI3K/Akt signaling pathway | Water extract of adlay hull | [ |
Figure 1Functional ingredients of adlay combat more than 20 chronic diseases.
Figure 2Actional relationship between functional components of adlay and chronic disease.
Relationship between functional components of adlay and chronic disease.
| Functional Ingredients | Chronic Diseases | Efficacy Number |
|---|---|---|
| Oils and triglycerides | Anti-cancer [ | 9 |
| Polysaccharides | Anti-cancer [ | 4 |
| Phenols | Anti-cancer [ | 7 |
| Coixol | Anti-cancer [ | 4 |
| Phytosterols | Anti-cancer [ | 8 |
| Resistant starch | Anti-cancer [ | 3 |